Open the mobile version, with barcode scanning
Class II Ongoing

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind.

Why: cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.

Company
Unichem Pharmaceuticals USA Inc.
East Brunswick, NJ, United States
Reported
Feb 11, 2026
Recall started
Jan 21, 2026
Where sold
US Nationwide and PR.
Amount
N/A
Full product description
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01
Lots / codes affected
Lot # GBHL24005A, Exp Date: 09/2026

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.